NSEGeneral Updates15h ago · 1 Sept 2026, 12:47 pm
General Updates
Jubilant Pharmova Limited · JUBLPHARMA
✦ AI SummaryRegulatory
Jubilant Pharmova Limited has received a Show Cause Notice from the Assistant Commissioner of Commercial taxes (Enforcement)-4, Mysore, proposing a demand of GST, interest, and penalty for the Financial Year 2022-2023. The company intends to file a detailed reply with documentary evidence and expects no financial or operational impact.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jubilant Pharmova Limited has informed the Exchange about General Updates - Receipt of Show Cause Notice by Jubilant Pharmova Limited - GST
Attachments (1)
📄pdf
Download →
JUBLPHARMA_01092026124717_JPM_GSTNotice.pdf
View document text
September 1, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange plaza,
Dalal Street, Bandra-Kurla Complex,
Mumbai - 400001 Bandra (E), Mumbai - 400051
Scrip Code: 530019 Scrip Code: JUBLPHARMA
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”)
Dear Sir/Madam,
Pursuant to Regulation 30 of the Listing Regulations read with Schedule III and the SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 with respect to receipt of
Show Cause Notice by Jubilant Pharmova Limited issued by the Assistant Commissioner of
Commercial taxes (Enforcement)-4, Mysore proposing demand of GST, Interest and penalty for the
Financial Year 2022—2023.
The information in the relevant format is enclosed as Annexure-A.
The Company is in the process of taking necessary action to file a detailed reply before the Assistant
Commissioner of Commercial taxes (Enforcement)-4, Mysore in response to the Show Cause Notice.
Date and time of occurrence of event is August 31, 2026, 1:00 PM (IST).
The above-mentioned document will be simultaneously posted on the Company's website at
www.jubilantpharmova.com.
We request you to take the same on record.
Thanking you,
Yours faithfully,
For Jubilant Pharmova Limited
Naresh Kapoor
Company Secretary
Annexure – A
Sr. Brief details of Name of the Court/ Expected financial Quantum of
No litigation opposing party tribunal/agenc implications, if any, demand (In Rs.
y where due to Crore)
litigation is compensation,
filed penalty etc.
1. The Company has The Assistant Reply will be The Show Cause GST (Tax) – Rs.
received Show Cause Commissioner filed before the Notice is factually and 33.58 Cr.
Notice on 31st August of Commercial Assistant legally incorrect, bad Interest – Rs.
2026 (at 1.00 PM) issued taxes Commissioner in law and has been 20.15 Cr.
by the Assistant (Enforcement)- of Commercial issued without Penalty – Rs.
Commissioner of 4, Mysore taxes verifying the facts and 33.58 Cr
Commercial taxes (Enforcement)- examining the issue Total –
(Enforcement)-4, 4, Mysore properly and no Rs.87.31 Cr.
Mysore proposing contesting the opportunity was
demand of tax, interest demand provided to the
and penalty on several Company before
issues such as alleged issue of the notice.
ineligible ITC, excess ITC The Company has a
availed, differential tax strong case in its
liability based on E- favour.
waybill records, etc.
The Company will file
a detailed reply on
merits with
documentary
evidences before the
Assistant
Commissioner of
Commercial taxes
(Enforcement)-4,
Mysore. Therefore,
the Company expects
no financial or
operational impact.